Bruce Berkowitz's Fairholme Capital Management will hold a 90-minute conference call with BofA CEO Brian Moynihan on Aug. 10 during which investors in the Fairholme Fund, which holds 92.6 million shares of the bank, will get to ask about its sagging share price.
Bank of America Corp. Chief Executive Officer Brian T. Moynihan, seeking to reverse a 28% stock slide this year, will subject himself to the “toughest questions” from fund manager Bruce Berkowitz's investors.
Berkowitz's Fairholme Capital Management LLC will hold a 90-minute conference call with Moynihan on Aug. 10, the Miami-based manager said yesterday in a statement. The event will help investors of Fairholme, with 92.6 million Bank of America shares as of March 31, understand why the Charlotte, N.C.-based lender is a core holding, Berkowitz said.
Bank of America's stock decline has helped to sink the returns of investors including Berkowitz, who was named U.S. domestic stock-fund manager of the decade last year by Morningstar Inc., and hedge-fund manager John Paulson. It's more common for executives to speak at conferences with research analysts than a big shareholder, said Jonathan Hatcher, a Jefferies Group Inc. credit strategist specializing in banks.
“It's unique -- I can't recollect the last time the CEO of a large firm agreed to something like this,” Hatcher said in an interview. “The market always appreciates executives being more open with the investment community, but I suspect it will be a repeat of what was discussed on the last earnings call.”
Berkowitz, 53, is seeking to reassure investors after his flagship Fairholme Fund declined 15 percent this year, trailing the Standard & Poor's 500 Index gain of less than 1 percent. In a report to investors this week, he said his strategy was to “embrace the hated” among stocks. Financial firms that have significant cash flows and narrowing restructuring costs are at a “tipping point,” he said.
Moynihan's Moves
Bank of America, the biggest U.S. lender by assets, rose 5 cents yesterday in New York trading after dropping to $9.32, the lowest since May 2009. Moynihan, 51, has forged settlements with buyers and insurers of defective mortgages, booking about $30 billion in accords and writedowns since taking over last year.
“I suppose desperate times call for desperate measures,” said Manal Mehta, a partner at Branch Hill Capital, a San Francisco-based hedge fund that has short positions on Bank of America stock. “While a push for greater transparency is always welcome, it isn't clear that Moynihan can give investors comfort that Bank of America has command over its mortgage liabilities.”
The CEO “appreciates the opportunity to discuss the company's strategy and performance with investors and to take their questions, and he does so regularly in a variety of venues,” said Larry DiRita, a Bank of America spokesman.
Reaching Goals
Bank of America will generate enough earnings to comply with new capital standards, end liabilities from the 2008 takeover of Countrywide Financial Corp., and return funds to investors, Berkowitz said yesterday. The lender has the “management in place” to reach these goals, he said.
“Skeptics are invited to participate on the call,” Berkowitz said in the statement, adding that the comments in the release were solely his opinions. Moynihan will make opening remarks, then Berkowitz will ask him the “toughest questions” submitted by e-mail to askbrian@fairholmefunds.com, he said.
The fund manager “is probably trying to put pressure on Bank of America to clarify its strategy going forward in addressing the legacy issues they still face,” said Jonathan Finger, whose family-owned investment company, Finger Interests Ltd., owns 1.1 million Bank of America shares. “If you listen to the conference calls, it's difficult to understand from Moynihan's responses what the company's strategy is.”
Berkowitz previously hosted a conference call with the head of a company that he considered undervalued. In March 2009, he peppered then-Pfizer Inc. CEO Jeffrey Kindler with questions about the prospects for the firm, his biggest holding at the time. The world's largest drugmaker rose more than 30% that year after the event.
--Blooomberg News--